N Engl J Med 2015 May 31
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.
Related Questions
New answer by Medical Oncologist at University of Texas MD Anderson Cancer Center (March 26, 2017)
In a randomized study, the combination of nivolumab and ipilimumab has demonstrated superior progression free survival compared to nivolumab alone in patients with melanoma. H...